Update of a Phase 2 Study of Definitive Radiation Therapy With Concurrent Docetaxel and Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)

M. Yao; C. Woods; P. Savvides; P. Lavertu; R. Rezaee; C. Zender; P. Fu; M. Gibson; J. Wasman; M. Machtay

doi:10.1016/j.ijrobp.2013.11.063

Update of a Phase 2 Study of Definitive Radiation Therapy With Concurrent Docetaxel and Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.11.063 ◽

2014 ◽

Vol 88 (2) ◽

pp. 480-481

Author(s):

M. Yao ◽

C. Woods ◽

P. Savvides ◽

P. Lavertu ◽

R. Rezaee ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Advanced Squamous Cell Carcinoma ◽

Phase 2 ◽

Phase 2 Study

Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study

The Lancet Oncology ◽

10.1016/s1470-2045(20)30327-2 ◽

2020 ◽

Vol 21 (9) ◽

pp. 1173-1187 ◽

Cited By ~ 6

Author(s):

Xu-Shan Sun ◽

Yungan Tao ◽

Christophe Le Tourneau ◽

Yoann Pointreau ◽

Christian Sire ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

High Risk ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

High Dose ◽

Advanced Squamous Cell Carcinoma ◽

Phase 2 ◽

Double Blind ◽

Phase 2 Study

Nivolumab and Ipilimumab Combined with Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: In-field Toxicity Analysis of a Phase I Clinical Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.2289 ◽

2020 ◽

Vol 108 (3) ◽

pp. S106-S107

Author(s):

G. Manukian ◽

J. Johnson ◽

A. Luginbuhl ◽

J.M. Curry ◽

D. Cognetti ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Advanced Squamous Cell Carcinoma ◽

Toxicity Analysis

Hyperfractionated accelerated radiation therapy with concurrent interferon alpha and isotretinoin for patients with locally advanced squamous cell carcinoma of the head and neck

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/0360-3016(94)90805-2 ◽

1994 ◽

Vol 30 ◽

pp. 258

Author(s):

J. Vrouvas ◽

G. Kolitsi ◽

C. Kyprianou ◽

Ph. Angelakis

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Interferon Alpha ◽

Squamous Cell ◽

Locally Advanced ◽

Advanced Squamous Cell Carcinoma ◽

Accelerated Radiation Therapy

Phase 2, Randomized Trial (CONCERT-2) of Panitumumab (PMAB) Plus Radiotherapy (PRT) Compared with Chemoradiotherapy (CRT) in Patients (PTS) with Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LASCCHN)

Annals of Oncology ◽

10.1093/annonc/mds402 ◽

2012 ◽

Vol 23 ◽

pp. ix334 ◽

Cited By ~ 9

Author(s):

J. Giralt ◽

J.M. Trigo ◽

S. Nuyts ◽

E.M. Ozsahin ◽

K. Skladowski ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Randomized Trial ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Advanced Squamous Cell Carcinoma ◽

Phase 2

Faculty Opinions recommendation of Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.738449325.793581438 ◽

2020 ◽

Author(s):

Sandra Nuyts ◽

Heleen Bollen

Keyword(s):

Squamous Cell Carcinoma ◽

High Risk ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

High Dose ◽

Advanced Squamous Cell Carcinoma ◽

Phase 2 ◽

Double Blind ◽

Phase 2 Study

Phase 2 Bioadjuvant Study of Interferon Alfa-2a, Isotretinoin, and Vitamin E in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Archives of Otolaryngology - Head and Neck Surgery ◽

10.1001/archotol.131.4.304 ◽

2005 ◽

Vol 131 (4) ◽

pp. 304 ◽

Cited By ~ 33

Author(s):

Jose A. Seixas-Silva ◽

Thomas Richards ◽

Fadlo R. Khuri ◽

H. Samuel Wieand ◽

Ed Kim ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Vitamin E ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Interferon Alfa ◽

Advanced Squamous Cell Carcinoma ◽

Phase 2

Conventional Radiation Therapy with Chemo Boost in Locally Advanced Squamous Cell Carcinoma of Head and Neck

International Journal of Contemporary Medical Research [IJCMR] ◽

10.21276/ijcmr.2019.6.4.8 ◽

2019 ◽

Vol 6 (4) ◽

Author(s):

R. Deivanayagam ◽

Heber Anandan

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Advanced Squamous Cell Carcinoma ◽

Conventional Radiation ◽

Conventional Radiation Therapy

A phase 2 trial of inductionnab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck

Cancer ◽

10.1002/cncr.27741 ◽

2012 ◽

Vol 119 (4) ◽

pp. 766-773 ◽

Cited By ~ 18

Author(s):

Douglas Adkins ◽

Jessica Ley ◽

Kathryn Trinkaus ◽

Wade Thorstad ◽

James Lewis ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Advanced Squamous Cell Carcinoma ◽

Phase 2 ◽

Phase 2 Trial

Spatially Fractionated Radiation Therapy and Chemotherapy-IMRT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2007.07.1661 ◽

2007 ◽

Vol 69 (3) ◽

pp. S470

Author(s):

J.A. Penagaricano ◽

P. Spring ◽

E. Moros ◽

V. Ratanatharathorn

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Advanced Squamous Cell Carcinoma ◽

Fractionated Radiation Therapy ◽

Fractionated Radiation

8519 A phase 2, randomized trial (CONCERT-1) of chemoradiotherapy with or without panitumumab in patients (pts) with unresected, locally advanced squamous cell carcinoma of the head and neck (SCCHN): Interim pooled safety analysis

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71610-6 ◽

2009 ◽

Vol 7 (2) ◽

pp. 476

Author(s):

A. Fortin ◽

A. Cmelak ◽

R. Mesía ◽

H. Minn ◽

A.T.C. Chan ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Randomized Trial ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Safety Analysis ◽

Advanced Squamous Cell Carcinoma ◽

Phase 2